Pharmaceutical Technology on MSN15d
Jazz Pharmaceuticals bids for Chimerix in $935m dealJazz Pharmaceuticals has announced a definitive agreement to acquire Chimerix, a US-based biotech firm, for approximately $935m in cash. The deal, disclosed on Wednesday 5 March, will see Jazz pay $8.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback